Latest Vestal Point Capital, LP Stock Portfolio

Vestal Point Capital, LP Performance:

2024 Q4: -8.96%YTD: -13.36%

Performance for 2024 Q4 is -8.96%, and YTD is -13.36%.

About Vestal Point Capital, LP and 13F Hedge Fund Stock Holdings

Vestal Point Capital, LP is a hedge fund based in NEW YORK, NY. On 10-Aug-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.3 Billions. In it's latest 13F Holdings report, Vestal Point Capital, LP reported an equity portfolio of $1.7 Billions as of 31 Dec, 2024.

The top stock holdings of Vestal Point Capital, LP are JAZZ, CYTK, MRK. The fund has invested 7.1% of it's portfolio in JAZZ PHARMACEUTICALS PLC and 6.6% of portfolio in CYTOKINETICS INC.

The fund managers got completely rid off INARI MEDICAL INC (NARI), AGIOS PHARMACEUTICALS INC (AGIO) and JANUX THERAPEUTICS INC (JANX) stocks. They significantly reduced their stock positions in ZYMEWORKS INC (ZYME), MACROGENICS INC (MGNX) and MONTE ROSA THERAPEUTICS INC (GLUE). Vestal Point Capital, LP opened new stock positions in MERCK & CO INC (MRK), NUVALENT INC (NUVL) and VERA THERAPEUTICS INC (VERA). The fund showed a lot of confidence in some stocks as they added substantially to GERON CORP (GERN), APPLIED THERAPEUTICS INC (APLT) and ESTABLISHMENT LABS HOLDINGS IN (ESTA).

Vestal Point Capital, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Vestal Point Capital, LP made a return of -8.96% in the last quarter. In trailing 12 months, it's portfolio return was -13.36%.

New Buys

Ticker	$ Bought
merck & co inc	79,584,000
nuvalent inc	46,968,000
vera therapeutics inc	45,461,800
amicus therapeutics inc	31,557,000
astrazeneca plc	31,122,000
sarepta therapeutics inc	30,397,500
globus medical inc	26,880,800
nyxoah sa	23,393,700

New stocks bought by Vestal Point Capital, LP

Additions

Ticker	% Inc.
geron corp	947
applied therapeutics inc	904
establishment labs holdings in	650
sanofi sa	400
urogen pharma ltd	307
legend biotech corp	280
gsk plc	233
madrigal pharmaceuticals inc	216

Additions to existing portfolio by Vestal Point Capital, LP

Reductions

Ticker	% Reduced
zymeworks inc	-69.92
macrogenics inc	-66.27
monte rosa therapeutics inc	-54.3
insmed inc	-43.75
day one biopharmaceuticals inc	-42.4
uniqure nv	-36.32
tenax therapeutics inc	-33.77
arcellx inc	-29.63

Vestal Point Capital, LP reduced stake in above stock

Sold off

Ticker	$ Sold
inari medical inc	-63,922,000
prime medicine inc	-4,140,900
agios pharmaceuticals inc	-33,766,800
zevra therapeutics inc	-3,643,500
ardelyx inc	-3,445,000
relmada therapeutics inc	-1,587,600
janux therapeutics inc	-22,033,600
edwards lifesciences corp	-18,147,200

Vestal Point Capital, LP got rid off the above stocks

Sector Distribution

Vestal Point Capital, LP has about 78.1% of it's holdings in Healthcare sector.

Sector	%
Healthcare	78.1
Others	21.9

Market Cap. Distribution

Vestal Point Capital, LP has about 15.4% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
MID-CAP	39.7
UNALLOCATED	21.9
SMALL-CAP	21.5
LARGE-CAP	10.7
MEGA-CAP	4.7
MICRO-CAP	1.3

Stocks belong to which Index?

About 44.8% of the stocks held by Vestal Point Capital, LP either belong to S&P 500 or RUSSELL 2000 index.

Index	%
Others	55.2
RUSSELL 2000	38.6
S&P 500	6.2

Top 5 Winners (%)		%
CMRX	chimerix inc	274.2 %
QURE	uniqure nv	175.6 %
ONTX	traws pharma inc	78.0 %
TENX	tenax therapeutics inc	66.1 %
ATRA	atara biotherapeutics inc	63.5 %

Top 5 Winners ($)		$
QURE	uniqure nv	41.1 M
JAZZ	jazz pharmaceuticals plc	10.7 M
VRNA	verona pharma plc	3.9 M
CMRX	chimerix inc	3.6 M
MDGL	madrigal pharmaceuticals inc	2.9 M

Top 5 Losers (%)		%
APLT	applied therapeutics inc	-89.8 %
BDTX	black diamond therapeutics inc	-48.8 %
FATE	fate therapeutics inc	-47.8 %
SLDB	solid biosciences inc	-42.4 %
STRO	sutro biopharma inc	-36.5 %

Top 5 Losers ($)		$
APLT	applied therapeutics inc	-86.8 M
RARE	ultragenyx pharmaceutical inc	-15.6 M
KALV	kalvista pharmaceuticals inc	-13.7 M
CYTK	cytokinetics inc	-12.0 M
BDTX	black diamond therapeutics inc	-11.4 M

Vestal Point Capital, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Vestal Point Capital, LP

Vestal Point Capital, LP has 73 stocks in it's portfolio. About 42.2% of the portfolio is in top 10 stocks. APLT proved to be the most loss making stock for the portfolio. QURE was the most profitable stock for Vestal Point Capital, LP last quarter.

Last Reported on: 14 Feb, 2025

	Ticker	Namesorted descending	% Portfolio	Shares Held	$ Value	Type	% Change
	JAZZ	jazz pharmaceuticals plc	7.12	975,000	120,071,000	added	8.33
Historical Trend of JAZZ PHARMACEUTICALS PLC Position Held By Vestal Point Capital, LP What % of Portfolio is JAZZ?: Number of JAZZ shares held: Change in No. of Shares Held:
	CYTK	cytokinetics inc	6.55	2,350,000	110,544,000	added	56.67

	MRK	merck & co inc	4.72	800,000	79,584,000	new

		ascendis pharma a/s	4.24	520,000	71,588,400	added	108

	RARE	ultragenyx pharmaceutical inc	3.74	1,500,000	63,105,000	added	100

	INSM	insmed inc	3.68	900,000	62,136,000	reduced	-43.75

	BMRN	biomarin pharmaceutical inc	3.35	860,000	56,527,800	added	115

	QURE	uniqure nv	3.17	3,025,000	53,421,500	reduced	-36.32

	SLNO	soleno therapeutics inc	2.83	1,060,000	47,647,000	added	47.22

	NUVL	nuvalent inc	2.79	600,000	46,968,000	new

		structure therapeutics inc	2.77	1,725,000	46,782,000	added	50.00

	VERA	vera therapeutics inc	2.69	1,075,000	45,461,800	new

		immatics nv	2.64	6,275,000	44,615,200	added	67.33

	KALV	kalvista pharmaceuticals inc	2.40	4,770,000	40,401,900	added	19.25

	GERN	geron corp	2.31	11,000,000	38,940,000	added	947

	ATXS	astria therapeutics inc	2.22	4,180,000	37,369,200	added	4.5

	ACLX	arcellx inc	2.16	475,000	36,427,800	reduced	-29.63

		sanofi sa	2.14	750,000	36,172,500	added	400

		gsk plc	2.00	1,000,000	33,820,000	added	233

	SVRA	savara inc	1.96	10,775,000	33,079,200	added	33.19